Home About Us Services Markets Resarch Online Trading Back Office Contact Us Download
Shukra Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations
 BSE Code
 524632
ISIN Demat
INE551C01028
Book Value
10.1085326
Mar.Cap(Rs.Cr)
528.26
P/E
28.52
Face Value
10
Go
Your are on :   Markets   |  Company Profile   |  Key Financial Ratios
   YearsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debt-Equity Ratio0.200.410.570.460.32
Long Term Debt-Equity Ratio0.170.400.570.460.32
Current Ratio1.121.231.501.501.55
Fixed Assets1.580.600.340.460.24
Inventory16.557.287.3016.5432.24
Debtors3.132.391.272.061.60
Interest Cover Ratio16.894.5211.000.000.00
PBIDTM (%)11.1514.4916.0711.2925.57
PBITM (%)8.026.392.950.5111.04
PBDTM (%)10.6713.0815.8011.2925.57
CPM (%)10.6211.7614.3810.9221.48
APATM (%)7.503.661.250.156.96
ROCE (%)18.845.811.350.363.60
RONW (%)21.184.690.900.133.03
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)